Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Discontinuation of Imatinib: A Tyrosine Kinase Inhibitor Withdrawal Syndrome? Reply

被引：11

作者：

Rousselot, Philippe ^{[1
]}

Charbonnier, Aude ^{[2
]}

Cony-Makhoul, Pascale ^{[3
]}

Agape, Philippe ^{[4
]}

Nicolini, Franck E. ^{[5
]}

Varet, Bruno ^{[6
,7
]}

Gardembas, Martine ^{[8
]}

Etienne, Gabriel ^{[9
]}

Rea, Delphine ^{[10
]}

Roy, Lydia ^{[11
]}

Escoffre-Barbe, Martine ^{[12
]}

Guerci-Bresler, Agnes ^{[13
]}

Tulliez, Michel ^{[14
]}

Prost, Stephane ^{[15
]}

Spentchian, Marc ^{[16
]}

Cayuela, Jean Michel ^{[10
]}

Reiffers, Josy ^{[17
]}

Chomel, Jean Claude ^{[18
,19
]}

Turhan, Ali ^{[18
,19
]}

Guilhot, Joelle ^{[20
]}

Guilhot, Francois ^{[20
]}

Mahon, Francois-Xavier ^{[21
,22
]}

机构：

[1] Univ Versailles St Quentin en Yvelines, Hop Mignot, Versailles, France

[2] Inst Paoli Calmette, Marseille, France

[3] Hop Annecy, Pringy, France

[4] Ctr Hop Univ CHU Reunion, Hop Felix Guyon, St Pierre, Reunion, France

[5] Ctr Hosp Lyon Sud, Pierre Benite, France

[6] Hop Necker Enfants Malad, AP HP, Paris, France

[7] Univ Paris 05, Paris, France

[8] CHU Angers, Angers, France

[9] Inst Bergonie, Bordeaux, France

[10] Hop St Louis, AP HP, Paris, France

[11] CHU Poitiers, INSERM, Clin Invest Ctr CIC 802, Poitiers, France

[12] Ctr Hosp Pontchaillou, Rennes, France

[13] CHU Brabois Vandoeuvre, Nancy, France

[14] Hop Henri Mondor, AP HP, Paris, France

[15] Inst Emerging Dis & Innovat Therapies, Fontenay Aux Roses, France

[16] Hop Mignot, Le Chesnay, France

[17] Inst Bergonie, Bordeaux, France

[18] Univ Poitiers, INSERM U935, Le Kremlin Bicetre, France

[19] Univ Paris 11, Le Kremlin Bicetre, France

[20] CHU Poitiers, INSERM CIC 802, Poitiers, France

[21] Hop Haut Leveque, INSERM U1035, Bordeaux, France

[22] Univ Bordeaux Segalen, Bordeaux, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 25期

关键词：

COMPLETE MOLECULAR REMISSION; CHRONIC MYELOGENOUS LEUKEMIA; MESYLATE; THERAPY; DISEASE;

D O I：

10.1200/JCO.2014.56.3858

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2823 / +

页数：3

共 50 条

[31] Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Single US Center Experience
Khoury, H. Jean
Heffner, Leonard T., Jr.
Arellano, Martha
Jillella, Anand P.
Kota, Vamsi K.
Winton, Elliott F.
BLOOD, 2015, 126 (23)
[32] Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success
Inzoli, Elena
Aroldi, Andrea
Piazza, Rocco
Gambacorti-Passerini, Carlo
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (08) : 1075 - 1085
[33] Discontinuation of Imatinib in Japanese Patients with Chronic Myeloid Leukemia
Takahashi, Naoto
Kyo, Taiichi
Maeda, Yasuhiro
Sugihara, Takashi
Usuki, Kensuke
Kawaguchi, Tatsuya
Usui, Noriko
Okamoto, Shinichiro
Ohe, Yokiko
Ohtake, Shigeki
Kitamura, Kunio
Yamamoto, Masahide
Teshima, Hirofumi
Motoji, Toshiko
Tamaki, Toshiharu
Sawada, Kenichi
Ohyashiki, Kazuma
BLOOD, 2011, 118 (21) : 1604 - 1605
[34] Discontinuation of tyrosine kinase inhibitor in chronic myeloid leukemia: a retrospective cohort in east occitania
Robin, J. B.
Theron, A.
Quittet, P.
Exbrayat, C.
Gaillard, J. B.
Lavabre-Bertrand, T.
David, S.
Saad, A.
Jourdan, E.
Cartron, G.
ANNALS OF HEMATOLOGY, 2022, 101 (05) : 1015 - 1022
[35] Discontinuation of tyrosine kinase inhibitor in chronic myeloid leukemia: a retrospective cohort in east occitania
J. B. Robin
A. Theron
P. Quittet
C. Exbrayat
J. B. Gaillard
T. Lavabre-Bertrand
S. David
A. Saad
E. Jourdan
G. Cartron
Annals of Hematology, 2022, 101 : 1015 - 1022
[36] Musculoskeletal symptoms in chronic myeloid leukemia patients after stopping tyrosine kinase inhibitors.
Diab, Maria
Jeyakunnar, Ghayathri
Schiffer, Charles Alan
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[37] The spectrum of musculoskeletal symptoms in patients with chronic myeloid leukemia after stopping tyrosine kinase inhibitors
Diab, Maria
Schiffer, Charles A.
LEUKEMIA RESEARCH, 2019, 79 : 1 - 2
[38] Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia patients - worldwide battlefield
Dvorak, P.
Lysak, D.
Vokurka, S.
NEOPLASMA, 2015, 62 (02) : 167 - 171
[39] A PROSPECTIVE STUDY OF THE MONITORING OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA UPON WITHDRAWAL OF TYROSINE KINASE INHIBITOR THERAPY
Turkina, A. G.
Petrova, A. N.
Chelysheva, E. Yu
Shukhov, O. A.
Tsyba, O. N.
Golenkov, A. K.
Vysotskaia, L. L.
Bykova, A., V
Nemchenko, I. S.
Gusarova, G. A.
Pospelova, O. M.
Gurianova, M. A.
Martynkevich, I. S.
Abdullaev, A. O.
Sudarikov, A. B.
Kulikov, S. M.
Savchenko, V. G.
GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2020, 65 (04): : 370 - 385
[40] Outcome of four patients with chronic myeloid leukemia after imatinib mesylate discontinuation
Merante, Serena
Orlandi, Ester
Bernasconi, Paolo
Calatroni, Silvia
Boni, Marina
Lazzarino, Mario
HAEMATOLOGICA, 2005, 90 (07) : 979 - 981

← 1 2 3 4 5 →